Cervical cancer (English Wikipedia)

Canavan TP, Doshi NR (March 2000). "Cervical cancer". American Family Physician. 61 (5): 1369–1376. PMID 10735343. Archived from the original on 6 February 2005.

abc.net.au

Bradford G (16 October 2006). "Janette Howard speaks on her battle with cervical cancer". Australian Broadcasting Corporation. Archived from the original on 3 November 2012.

accf.org.au

Australian Cervical Cancer Foundation. "Vision and Mission". Australian Cervical Cancer Foundation. Archived from the original on 12 May 2013.
Australian Cervical Cancer Foundation. "Our People". Australian Cervical Cancer Foundation. Archived from the original on 12 May 2013.

aihw.gov.au

"National Cervical Screening Program monitoring report 2022, Summary". Australian Institute of Health and Welfare. December 2022. Retrieved 21 January 2023.

appliedradiationoncology.com

Schmitt, Luiza G.; Amarnath, Sudha R. (1 September 2023). "Late Effects of Pelvic Radiation Therapy in the Female Patient: A Comprehensive Review". Applied Radiation Oncology. 2023 (3): 13–24. doi:10.37549/ARO-D-23-00016. Retrieved 16 October 2024.

archive.org

Campbell S, Monga A (2006). Gynaecology by Ten Teachers (18th ed.). Hodder Education. ISBN 978-0-340-81662-2.

archives-ouvertes.fr

hal-univ-rennes1.archives-ouvertes.fr

Sardain H, Lavoue V, Redpath M, Bertheuil N, Foucher F, Levêque J (August 2015). "Curative pelvic exenteration for recurrent cervical carcinoma in the era of concurrent chemotherapy and radiation therapy. A systematic review" (PDF). European Journal of Surgical Oncology. 41 (8): 975–985. doi:10.1016/j.ejso.2015.03.235. PMID 25922209. S2CID 21911045.

baymoon.com

Dolson L (2001). "Trachelectomy". Archived from the original on 27 September 2007. Retrieved 2 December 2007.

books.google.com

Kufe D (2009). Holland-Frei cancer medicine (8th ed.). New York: McGraw-Hill Medical. p. 1299. ISBN 978-1-60795-014-1. Archived from the original on 1 December 2015.
Carraher Jr CE (2014). Carraher's polymer chemistry (9th ed.). Boca Raton: Taylor & Francis. p. 385. ISBN 978-1-4665-5203-6. Archived from the original on 22 October 2015.
Dillman RK, Oldham RO, eds. (2009). Principles of cancer biotherapy (5th ed.). Dordrecht: Springer. p. 149. ISBN 978-90-481-2289-9. Archived from the original on 29 October 2015.
Rosenblatt A, de Campos Guidi HG (6 August 2009). Human Papillomavirus: A Practical Guide for Urologists. Springer Science & Business Media. ISBN 978-3-540-70974-9.

businesswire.com

"Seagen and Genmab Announce FDA Accelerated Approval for Tivdak (tisotumab vedotin-tftv) in Previously Treated Recurrent or Metastatic Cervical Cancer". Seagen. 20 September 2021. Retrieved 20 September 2021 – via Business Wire.

cambridge.org

dictionary.cambridge.org

"CERVICAL | meaning in the Cambridge English Dictionary". dictionary.cambridge.org. Retrieved 5 October 2019.

cancer.ca

"Cervical Cancer statistics". Canadian Cancer Society. May 2022. Retrieved 21 January 2023.
"As a trans man, do I need to get screened for cervical cancer?". Canadian Cancer Society. Retrieved 21 January 2023.
"As a trans woman, do I need to get screened for cervical cancer?". Canadian Cancer Society. Retrieved 21 January 2023.

cancer.gov

"Cervical Cancer Treatment (PDQ®)". NCI. 14 March 2014. Archived from the original on 5 July 2014. Retrieved 24 June 2014.
"Cervical Cancer Treatment (PDQ®)". National Cancer Institute. 14 March 2014. Archived from the original on 5 July 2014. Retrieved 25 June 2014.
"Cervical Cancer Prevention (PDQ®)". National Cancer Institute. 27 February 2014. Archived from the original on 6 July 2014. Retrieved 25 June 2014.
"Human Papillomavirus (HPV) Vaccines". National Cancer Institute. 29 December 2011. Archived from the original on 4 July 2014. Retrieved 25 June 2014.
"Defining Cancer". National Cancer Institute. 17 September 2007. Archived from the original on 25 June 2014. Retrieved 10 June 2014.
"HPV and Cancer - NCI". www.cancer.gov. 1 March 2019. Retrieved 13 February 2024.
"Cervical Cancer Prevention". PDQ. Bethesda, MD: National Cancer Institute, National Institutes of Health. 26 December 2022.

seer.cancer.gov

"SEER Stat Fact Sheets: Cervix Uteri Cancer". NCI. National Cancer Institute. 10 November 2014. Archived from the original on 6 July 2014. Retrieved 18 June 2014.
"Cancer Stat Facts: Cervical Cancer". National Cancer Institute SEER Program. Retrieved 4 June 2019.

cancer.org

"Global Cancer Facts & Figures 3rd Edition" (PDF). 2015. p. 9. Archived (PDF) from the original on 22 August 2017. Retrieved 29 August 2017.
"Cervical Cancer Prevention and Early Detection". Cancer. Archived from the original on 10 July 2015.
"What Causes Cancer of the Cervix?". American Cancer Society. 30 November 2006. Archived from the original on 13 October 2007. Retrieved 2 December 2007.
"What Is Cervical Cancer?". American Cancer Society.
"Cervical Cancer Treatment Options | Treatment Choices by Stage". www.cancer.org. Retrieved 12 September 2020.
"Survival Rates for Cervical Cancer". American Cancer Society. 3 January 2020. Archived from the original on 27 February 2022. Retrieved 27 February 2022.
"Chemotherapy for Cervical Cancer". www.cancer.org. American Cancer Society. 28 June 2024. Retrieved 24 October 2024.

canceraustralia.gov.au

"Cervical cancer in Australia statistics". Australian Government- Cancer Australia. 18 August 2022. Retrieved 21 January 2023.

cancerhelp.org.uk

"Cervical cancer statistics and prognosis". Cancer Research UK. Archived from the original on 20 May 2007. Retrieved 24 March 2007.

cancerresearchuk.org

"Cervical cancer – Types and grades". Cancer Research UK.
"Cervical cancer statistics". Cancer Research UK. Archived from the original on 7 October 2014. Retrieved 27 October 2014.
"I'm trans or non-binary, does this affect my cancer screening?". Cancer Research UK. 10 October 2019. Retrieved 21 January 2023.

info.cancerresearchuk.org

"Cancer Research UK website". Archived from the original on 16 January 2009. Retrieved 3 January 2009.

cancerscreening.nhs.uk

"Liquid Based Cytology (LBC): NHS Cervical Screening Programme". Archived from the original on 8 January 2011. Retrieved 1 October 2010.

cdc.gov

"Cervical Cancer Screening Guidelines for Average-Risk Women" (PDF). cdc.gov. Archived (PDF) from the original on 1 February 2015. Retrieved 8 November 2014.

clevelandclinic.org

my.clevelandclinic.org

"Cervical Dysplasia: Causes, Symptoms, Diagnosis & Treatment". Cleveland Clinic. Retrieved 16 November 2023.

doi.org

Bosch FX, de Sanjosé S (2007). "The epidemiology of human papillomavirus infection and cervical cancer". Disease Markers. 23 (4): 213–227. doi:10.1155/2007/914823. PMC 3850867. PMID 17627057.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (May 2021). "Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries". CA: A Cancer Journal for Clinicians. 71 (3): 209–249. doi:10.3322/caac.21660. PMID 33538338. S2CID 231804598.
Tarney CM, Han J (2014). "Postcoital bleeding: a review on etiology, diagnosis, and management". Obstetrics and Gynecology International. 2014: 192087. doi:10.1155/2014/192087. PMC 4086375. PMID 25045355.
Dunne EF, Park IU (December 2013). "HPV and HPV-associated diseases". Infectious Disease Clinics of North America. 27 (4): 765–778. doi:10.1016/j.idc.2013.09.001. PMID 24275269.
Ramachandran D, Dörk T (October 2021). "Genomic Risk Factors for Cervical Cancer". Cancers. 13 (20): 5137. doi:10.3390/cancers13205137. PMC 8533931. PMID 34680286.
Tewari, Krishnansu S. (2 January 2025). "Cervical Cancer". New England Journal of Medicine. 392 (1): 56–71. doi:10.1056/NEJMra2404457.
Tran NP, Hung CF, Roden R, Wu TC (2014). "Control of HPV Infection and Related Cancer Through Vaccination". Viruses and Human Cancer. Recent Results in Cancer Research. Vol. 193. pp. 149–171. doi:10.1007/978-3-642-38965-8_9. ISBN 978-3-642-38964-1. PMID 24008298.
Donnez J (April 2020). "An update on uterine cervix pathologies related to infertility". Fertility and Sterility. 113 (4): 683–684. doi:10.1016/j.fertnstert.2020.02.107. PMID 32228872.
Canfell K, Kim JJ, Brisson M, Keane A, Simms KT, Caruana M, et al. (February 2020). "Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries". Lancet. 395 (10224): 591–603. doi:10.1016/S0140-6736(20)30157-4. PMC 7043006. PMID 32007142.
Li H, Wu X, Cheng X (July 2016). "Advances in diagnosis and treatment of metastatic cervical cancer". Journal of Gynecologic Oncology. 27 (4): e43. doi:10.3802/jgo.2016.27.e43. PMC 4864519. PMID 27171673.
Gadducci A, Barsotti C, Cosio S, Domenici L, Riccardo Genazzani A (August 2011). "Smoking habit, immune suppression, oral contraceptive use, and hormone replacement therapy use and cervical carcinogenesis: a review of the literature". Gynecological Endocrinology. 27 (8): 597–604. doi:10.3109/09513590.2011.558953. PMID 21438669. S2CID 25447563.
Snijders PJ, Steenbergen RD, Heideman DA, Meijer CJ (January 2006). "HPV-mediated cervical carcinogenesis: concepts and clinical implications". The Journal of Pathology. 208 (2): 152–164. doi:10.1002/path.1866. PMID 16362994. S2CID 25400770.
Marrazzo JM, Koutsky LA, Kiviat NB, Kuypers JM, Stine K (June 2001). "Papanicolaou test screening and prevalence of genital human papillomavirus among women who have sex with women". American Journal of Public Health. 91 (6): 947–952. doi:10.2105/AJPH.91.6.947. PMC 1446473. PMID 11392939.
Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, et al. (February 2003). "Epidemiologic classification of human papillomavirus types associated with cervical cancer". The New England Journal of Medicine. 348 (6): 518–527. doi:10.1056/NEJMoa021641. hdl:2445/122831. PMID 12571259. S2CID 1451343.
Peng, Qiu; Wang, Lujuan; Zuo, Liang; Gao, Shuichao; Jiang, Xianjie; Han, Yaqian; Lin, Jinguan; Peng, Mingjing; Wu, Nayiyuan; Tang, Yanyan; Tian, Hao; Zhou, Yujuan; Liao, Qianjin (January 2024). "HPV E6/E7: insights into their regulatory role and mechanism in signaling pathways in HPV-associated tumor". Cancer Gene Therapy. 31 (1): 9–17. doi:10.1038/s41417-023-00682-3.
Luhn P, Walker J, Schiffman M, Zuna RE, Dunn ST, Gold MA, et al. (February 2013). "The role of co-factors in the progression from human papillomavirus infection to cervical cancer". Gynecologic Oncology. 128 (2): 265–270. doi:10.1016/j.ygyno.2012.11.003. PMC 4627848. PMID 23146688.
Remschmidt C, Kaufmann AM, Hagemann I, Vartazarova E, Wichmann O, Deleré Y (March 2013). "Risk factors for cervical human papillomavirus infection and high-grade intraepithelial lesion in women aged 20 to 31 years in Germany". International Journal of Gynecological Cancer. 23 (3): 519–526. doi:10.1097/IGC.0b013e318285a4b2. PMID 23360813. S2CID 205679729.
Agorastos T, Miliaras D, Lambropoulos AF, Chrisafi S, Kotsis A, Manthos A, Bontis J (July 2005). "Detection and typing of human papillomavirus DNA in uterine cervices with coexistent grade I and grade III intraepithelial neoplasia: biologic progression or independent lesions?". European Journal of Obstetrics, Gynecology, and Reproductive Biology. 121 (1): 99–103. doi:10.1016/j.ejogrb.2004.11.024. PMID 15949888.
Jensen KE, Schmiedel S, Frederiksen K, Norrild B, Iftner T, Kjær SK (November 2012). "Risk for cervical intraepithelial neoplasia grade 3 or worse in relation to smoking among women with persistent human papillomavirus infection". Cancer Epidemiology, Biomarkers & Prevention. 21 (11): 1949–1955. doi:10.1158/1055-9965.EPI-12-0663. PMC 3970163. PMID 23019238.
Asthana S, Busa V, Labani S (April 2020). "Oral contraceptives use and risk of cervical cancer-A systematic review & meta-analysis". European Journal of Obstetrics, Gynecology, and Reproductive Biology. 247: 163–175. doi:10.1016/j.ejogrb.2020.02.014. PMID 32114321. S2CID 211728228.
Cronjé HS (February 2004). "Screening for cervical cancer in developing countries". International Journal of Gynaecology and Obstetrics. 84 (2): 101–108. doi:10.1016/j.ijgo.2003.09.009. PMID 14871510. S2CID 21356776.
Athanasiou A, Veroniki AA, Efthimiou O, Kalliala I, Naci H, Bowden S, et al. (August 2022). "Comparative effectiveness and risk of preterm birth of local treatments for cervical intraepithelial neoplasia and stage IA1 cervical cancer: a systematic review and network meta-analysis". The Lancet. Oncology. 23 (8): 1097–1108. doi:10.1016/S1470-2045(22)00334-5. PMC 9630146. PMID 35835138.
"Prevention of cervical cancer: what are the risks and benefits of different treatments?". NIHR Evidence (Plain English summary). National Institute for Health and Care Research. 10 November 2023. doi:10.3310/nihrevidence_60599. S2CID 265201829.
Pannu HK, Corl FM, Fishman EK (September–October 2001). "CT evaluation of cervical cancer: spectrum of disease". Radiographics. 21 (5): 1155–1168. doi:10.1148/radiographics.21.5.g01se311155. PMID 11553823.
Galaal K, Bryant A, Deane KH, Al-Khaduri M, Lopes AD (December 2011). "Interventions for reducing anxiety in women undergoing colposcopy". The Cochrane Database of Systematic Reviews. 2022 (12): CD006013. doi:10.1002/14651858.cd006013.pub3. PMC 4161490. PMID 22161395.
Salcedo MP, Phoolcharoen N, Schmeler KM (2022). "Intraepithelial neoplasia of the lower genital tract (cervix, vagina, vulva)". Comprehensive Gynecology. Elsevier. pp. 637–647.e2. doi:10.1016/b978-0-323-65399-2.00038-3. ISBN 978-0-323-65399-2.
Image by Mikael Häggström, MD. Source for caption: Ghosh A, Nirupama M, Padmanabha N, Kini H (2020). "Assessment of p16 and Ki67 Immunohistochemistry Expression in Squamous Intraepithelial Lesion with Cytohistomorphological Correlation". Iran J Pathol. 15 (4): 268–273. doi:10.30699/ijp.2020.112421.2208. PMC 7477676. PMID 32944038.
Mulita F, Iliopoulos F, Kehagias I (September 2020). "A rare case of gastric-type mucinous endocervical adenocarcinoma in a 59-year-old woman". Przeglad Menopauzalny = Menopause Review. 19 (3): 147–150. doi:10.5114/pm.2020.99563. PMC 7573334. PMID 33100952.
Bhatla N, Berek JS, Cuello Fredes M, Denny LA, Grenman S, Karunaratne K, et al. (April 2019). "Revised FIGO staging for carcinoma of the cervix uteri". International Journal of Gynaecology and Obstetrics. 145 (1): 129–135. doi:10.1002/ijgo.12749. PMID 30656645. S2CID 58656013.
Payne N, Chilcott J, McGoogan E (2000). "Liquid-based cytology in cervical screening: a rapid and systematic review". Health Technology Assessment. 4 (18): 1–73. doi:10.3310/hta4180. PMID 10932023.
Karnon J, Peters J, Platt J, Chilcott J, McGoogan E, Brewer N (May 2004). "Liquid-based cytology in cervical screening: an updated rapid and systematic review and economic analysis". Health Technology Assessment. 8 (20): iii, 1-iii, 78. doi:10.3310/hta8200. PMID 15147611.
Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U, Segnan N, et al. (March 2010). "European Guidelines for Quality Assurance in Cervical Cancer Screening. Second edition--summary document". Annals of Oncology. 21 (3): 448–458. doi:10.1093/annonc/mdp471. PMC 2826099. PMID 20176693.
Staley H, Shiraz A, Shreeve N, Bryant A, Martin-Hirsch PP, Gajjar K (September 2021). "Interventions targeted at women to encourage the uptake of cervical screening". The Cochrane Database of Systematic Reviews. 2021 (9): CD002834. doi:10.1002/14651858.CD002834.pub3. PMC 8543674. PMID 34694000.
Committee on Practice Bulletins—Gynecology (November 2012). "ACOG Practice Bulletin Number 131: Screening for cervical cancer". Obstetrics and Gynecology. 120 (5): 1222–1238. doi:10.1097/AOG.0b013e318277c92a. PMID 23090560.
Karjane N, Chelmow D (June 2013). "New cervical cancer screening guidelines, again". Obstetrics and Gynecology Clinics of North America. 40 (2): 211–223. doi:10.1016/j.ogc.2013.03.001. PMID 23732026.
Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, et al. (August 2018). "Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement". JAMA. 320 (7): 674–686. doi:10.1001/jama.2018.10897. PMID 30140884.
Arrossi S, Temin S, Garland S, Eckert LO, Bhatla N, Castellsagué X, et al. (October 2017). "Primary Prevention of Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Guideline". Journal of Global Oncology. 3 (5): 611–634. doi:10.1200/JGO.2016.008151. PMC 5646902. PMID 29094100.
Medeiros LR, Rosa DD, da Rosa MI, Bozzetti MC, Zanini RR (October 2009). "Efficacy of human papillomavirus vaccines: a systematic quantitative review". International Journal of Gynecological Cancer. 19 (7): 1166–1176. doi:10.1111/IGC.0b013e3181a3d100. PMID 19823051. S2CID 24695684.
Kitano, Taito (24 March 2022). "Risk-Benefit Analysis of the 9-Valent HPV Vaccination for Adolescent Boys from an Individual Perspective". Japanese Journal of Infectious Diseases. 75 (2): 114–120. doi:10.7883/yoken.JJID.2021.367. PMID 34334535.
Manhart LE, Koutsky LA (November 2002). "Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis". Sexually Transmitted Diseases. 29 (11): 725–735. doi:10.1097/00007435-200211000-00018. PMID 12438912. S2CID 9869956.
Zhang X, Dai B, Zhang B, Wang Z (February 2012). "Vitamin A and risk of cervical cancer: a meta-analysis". Gynecologic Oncology. 124 (2): 366–373. doi:10.1016/j.ygyno.2011.10.012. PMID 22005522.
Myung SK, Ju W, Kim SC, Kim H (October 2011). "Vitamin or antioxidant intake (or serum level) and risk of cervical neoplasm: a meta-analysis". BJOG. 118 (11): 1285–1291. doi:10.1111/j.1471-0528.2011.03032.x. hdl:2027.42/86903. PMID 21749626. S2CID 38761694.
Baalbergen A, Veenstra Y, Stalpers L (January 2013). "Primary surgery versus primary radiotherapy with or without chemotherapy for early adenocarcinoma of the uterine cervix". The Cochrane Database of Systematic Reviews. 2021 (1): CD006248. doi:10.1002/14651858.CD006248.pub3. PMC 7387233. PMID 23440805.
Einhorn N, Tropé C, Ridderheim M, Boman K, Sorbe B, Cavallin-Ståhl E (2003). "A systematic overview of radiation therapy effects in cervical cancer (cervix uteri)". Acta Oncologica. 42 (5–6): 546–556. doi:10.1080/02841860310014660. PMID 14596512.
Chemoradiotherapy for Cervical Cancer Meta-analysis Collaboration (CCCMAC) (January 2010). "Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis". The Cochrane Database of Systematic Reviews. 2010 (1): CD008285. doi:10.1002/14651858.cd008285. PMC 7105912. PMID 20091664.
Chau JP, Liu X, Lo SH, Chien WT, Hui SK, Choi KC, Zhao J (March 2022). "Perioperative enhanced recovery programmes for women with gynaecological cancers". The Cochrane Database of Systematic Reviews. 2022 (3): CD008239. doi:10.1002/14651858.CD008239.pub5. PMC 8922407. PMID 35289396.
van Nagell JR, Greenwell N, Powell DF, Donaldson ES, Hanson MB, Gay EC (April 1983). "Microinvasive carcinoma of the cervix". American Journal of Obstetrics and Gynecology. 145 (8): 981–991. doi:10.1016/0002-9378(83)90852-9. PMID 6837683.
Lin Y, Zhou J, Dai L, Cheng Y, Wang J (September 2017). "Vaginectomy and vaginoplasty for isolated vaginal recurrence 8 years after cervical cancer radical hysterectomy: A case report and literature review". The Journal of Obstetrics and Gynaecology Research. 43 (9): 1493–1497. doi:10.1111/jog.13375. PMID 28691384. S2CID 42161609.
Kokka F, Bryant A, Brockbank E, Jeyarajah A (May 2014). "Surgical treatment of stage IA2 cervical cancer". The Cochrane Database of Systematic Reviews. 2018 (5): CD010870. doi:10.1002/14651858.cd010870.pub2. PMC 6513277. PMID 24874726.
Jones WB, Mercer GO, Lewis JL, Rubin SC, Hoskins WJ (October 1993). "Early invasive carcinoma of the cervix". Gynecologic Oncology. 51 (1): 26–32. doi:10.1006/gyno.1993.1241. PMID 8244170.
Burnett AF (February 2006). "Radical trachelectomy with laparoscopic lymphadenectomy: review of oncologic and obstetrical outcomes". Current Opinion in Obstetrics & Gynecology. 18 (1): 8–13. doi:10.1097/01.gco.0000192968.75190.dc. PMID 16493253. S2CID 22958941.
Plante M, Renaud MC, Hoskins IA, Roy M (July 2005). "Vaginal radical trachelectomy: a valuable fertility-preserving option in the management of early-stage cervical cancer. A series of 50 pregnancies and review of the literature". Gynecologic Oncology. 98 (1): 3–10. doi:10.1016/j.ygyno.2005.04.014. PMID 15936061.
Roy M, Plante M, Renaud MC, Têtu B (September 1996). "Vaginal radical hysterectomy versus abdominal radical hysterectomy in the treatment of early-stage cervical cancer". Gynecologic Oncology. 62 (3): 336–339. doi:10.1006/gyno.1996.0245. PMID 8812529.
Dargent D, Martin X, Sacchetoni A, Mathevet P (April 2000). "Laparoscopic vaginal radical trachelectomy: a treatment to preserve the fertility of cervical carcinoma patients". Cancer. 88 (8): 1877–1882. doi:10.1002/(SICI)1097-0142(20000415)88:8<1877::AID-CNCR17>3.0.CO;2-W. PMID 10760765.
Schlaerth JB, Spirtos NM, Schlaerth AC (January 2003). "Radical trachelectomy and pelvic lymphadenectomy with uterine preservation in the treatment of cervical cancer". American Journal of Obstetrics and Gynecology. 188 (1): 29–34. doi:10.1067/mob.2003.124. PMID 12548192.
Rogers L, Siu SS, Luesley D, Bryant A, Dickinson HO (May 2012). "Radiotherapy and chemoradiation after surgery for early cervical cancer". The Cochrane Database of Systematic Reviews. 5 (5): CD007583. doi:10.1002/14651858.cd007583.pub3. PMC 4171000. PMID 22592722.
Waggoner SE (June 2003). "Cervical cancer". Lancet. 361 (9376): 2217–2225. doi:10.1016/S0140-6736(03)13778-6. PMID 12842378. S2CID 24115541.
Falcetta FS, Medeiros LR, Edelweiss MI, Pohlmann PR, Stein AT, Rosa DD (November 2016). "Adjuvant platinum-based chemotherapy for early stage cervical cancer". The Cochrane Database of Systematic Reviews. 11 (11): CD005342. doi:10.1002/14651858.CD005342.pub4. PMC 4164460. PMID 27873308.
Nama V, Angelopoulos G, Twigg J, Murdoch JB, Bailey J, Lawrie TA (October 2018). "Type II or type III radical hysterectomy compared to chemoradiotherapy as a primary intervention for stage IB2 cervical cancer". The Cochrane Database of Systematic Reviews. 2018 (10): CD011478. doi:10.1002/14651858.cd011478.pub2. PMC 6516889. PMID 30311942.
Moon JY, Song IC, Ko YB, Lee HJ (April 2018). "The combination of cisplatin and topotecan as a second-line treatment for patients with advanced/recurrent uterine cervix cancer". Medicine. 97 (14): e0340. doi:10.1097/MD.0000000000010340. PMC 5902288. PMID 29620661.
Tangjitgamol S, Katanyoo K, Laopaiboon M, Lumbiganon P, Manusirivithaya S, Supawattanabodee B (December 2014). "Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer". The Cochrane Database of Systematic Reviews. 2019 (12): CD010401. doi:10.1002/14651858.cd010401.pub2. PMC 6402532. PMID 25470408.
Sardain H, Lavoue V, Redpath M, Bertheuil N, Foucher F, Levêque J (August 2015). "Curative pelvic exenteration for recurrent cervical carcinoma in the era of concurrent chemotherapy and radiation therapy. A systematic review" (PDF). European Journal of Surgical Oncology. 41 (8): 975–985. doi:10.1016/j.ejso.2015.03.235. PMID 25922209. S2CID 21911045.
Lanceley A, Fiander A, McCormack M, Bryant A, et al. (Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group) (November 2013). "Follow-up protocols for women with cervical cancer after primary treatment". The Cochrane Database of Systematic Reviews. 2014 (11): CD008767. doi:10.1002/14651858.CD008767.pub2. PMC 8969617. PMID 24277645.
Eleje GU, Eke AC, Igberase GO, Igwegbe AO, Eleje LI (March 2019). "Palliative interventions for controlling vaginal bleeding in advanced cervical cancer". The Cochrane Database of Systematic Reviews. 3 (3): CD011000. doi:10.1002/14651858.cd011000.pub3. PMC 6423555. PMID 30888060.
Colomban L, Le Tourneau C (July 2022). "Immunotherapy in Cervical Cancer: Advances and Perspectives". Cancers (Basel). 14 (15): 3803. doi:10.3390/cancers14153803. PMC 9330146. PMID 35955074.
Cohen, Camryn M.; Wentzensen, Nicolas; Castle, Philip E.; Schiffman, Mark; Zuna, Rosemary; Arend, Rebecca C.; Clarke, Megan A. (1 December 2022). "Racial and Ethnic Disparities in Cervical Cancer Incidence, Survival, and Mortality by Histologic Subtype". Journal of Clinical Oncology. 41 (5). ASCO Publications: 1059–1068. doi:10.1200/JCO.22.01424. PMC 9928618. PMID 36455190.
Nygård M (June 2011). "Screening for cervical cancer: when theory meets reality". BMC Cancer. 11: 240. doi:10.1186/1471-2407-11-240. PMC 3146446. PMID 21668947.
Muliira RS, Salas AS, O'Brien B (2016). "Quality of Life among Female Cancer Survivors in Africa: An Integrative Literature Review". Asia-Pacific Journal of Oncology Nursing. 4 (1): 6–17. doi:10.4103/2347-5625.199078. PMC 5297234. PMID 28217724.
Dutta T, Meyerson B, Agley J (2018). "African cervical cancer prevention and control plans: A scoping review". Journal of Cancer Policy. 16: 73–81. doi:10.1016/j.jcpo.2018.05.002. S2CID 81552501.
Schmitt, Luiza G.; Amarnath, Sudha R. (1 September 2023). "Late Effects of Pelvic Radiation Therapy in the Female Patient: A Comprehensive Review". Applied Radiation Oncology. 2023 (3): 13–24. doi:10.37549/ARO-D-23-00016. Retrieved 16 October 2024.
Huh, Jung Wook; Tanksley, Jarred; Chino, Junzo; Willett, Christopher G.; Dewhirst, Mark W. (1 July 2020). "Long-term Consequences of Pelvic Irradiation: Toxicities, Challenges, and Therapeutic Opportunities with Pharmacologic Mitigators". Clinical Cancer Research. 26 (13): 3079–3090. doi:10.1158/1078-0432.CCR-19-2744. ISSN 1078-0432. PMID 32098770. Retrieved 24 October 2024.
Cordeiro CN, Gemignani ML (March 2017). "Gynecologic Malignancies in Pregnancy: Balancing Fetal Risks With Oncologic Safety". Obstetrical & Gynecological Survey. 72 (3): 184–193. doi:10.1097/OGX.0000000000000407. PMC 5358514. PMID 28304416.
Hall MT, Simms KT, Lew JB, Smith MA, Brotherton JM, Saville M, Frazer IH, Canfell K (January 2019). "The projected timeframe until cervical cancer elimination in Australia: a modelling study". The Lancet. Public Health. 4 (1): e19 – e27. doi:10.1016/S2468-2667(18)30183-X. PMID 30291040. S2CID 52924713.
G C B, G C A. Other countries should copy Nepal's approach to tackling cervical cancer. Nature. 2025 Feb;638(8052):891. doi:doi:10.1038/d41586-025-00589-z | PMID: PMID 40000865.
Krishnatreya M, Kataki AC, Sharma JD, Nandy P, Gogoi G (2015). "Association of educational levels with survival in Indian patients with cancer of the uterine cervix". Asian Pacific Journal of Cancer Prevention. 16 (8): 3121–3123. doi:10.7314/apjcp.2015.16.8.3121. PMID 25921107.
Armstrong EP (April 2010). "Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types". Journal of Managed Care Pharmacy. 16 (3): 217–230. doi:10.18553/jmcp.2010.16.3.217. PMC 10437588. PMID 20331326. S2CID 14373353.
zur Hausen H (May 2002). "Papillomaviruses and cancer: from basic studies to clinical application". Nature Reviews. Cancer. 2 (5): 342–350. doi:10.1038/nrc798. PMID 12044010. S2CID 4991177.
Beachler DC, Kreimer AR, Schiffman M, Herrero R, Wacholder S, Rodriguez AC, et al. (January 2016). "Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection". Journal of the National Cancer Institute. 108 (1): djv302. doi:10.1093/jnci/djv302. PMC 4862406. PMID 26467666.
Kreimer AR, Herrero R, Sampson JN, Porras C, Lowy DR, Schiller JT, et al. (August 2018). "Evidence for single-dose protection by the bivalent HPV vaccine-Review of the Costa Rica HPV vaccine trial and future research studies". Vaccine. 36 (32 Pt A): 4774–4782. doi:10.1016/j.vaccine.2017.12.078. PMC 6054558. PMID 29366703.
Syverton, J. T.; Berry, G. P. (1935). "Carcinoma in the Cottontail Rabbit Following Spontaneous Virus Papilloma (Shope)". Experimental Biology and Medicine. 33 (3): 399–400. doi:10.3181/00379727-33-8386P. S2CID 88311393.
Heins HC, Dennis EJ, Pratthomas HR (October 1958). "The possible role of smegma in carcinoma of the cervix". American Journal of Obstetrics and Gynecology. 76 (4): 726–33, discussion 733–5. doi:10.1016/0002-9378(58)90004-8. PMID 13583012.
Dürst M, Gissmann L, Ikenberg H, zur Hausen H (June 1983). "A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions". Proceedings of the National Academy of Sciences of the United States of America. 80 (12): 3812–3815. Bibcode:1983PNAS...80.3812D. doi:10.1073/pnas.80.12.3812. PMC 394142. PMID 6304740..
Lowy DR, Schiller JT (May 2006). "Prophylactic human papillomavirus vaccines". The Journal of Clinical Investigation. 116 (5): 1167–1173. doi:10.1172/JCI28607. PMC 1451224. PMID 16670757.
McNeil C (April 2006). "Who invented the VLP cervical cancer vaccines?". Journal of the National Cancer Institute. 98 (7): 433. doi:10.1093/jnci/djj144. PMID 16595773.
Tiro JA, Meissner HI, Kobrin S, Chollette V (February 2007). "What do women in the U.S. know about human papillomavirus and cervical cancer?". Cancer Epidemiology, Biomarkers & Prevention. 16 (2): 288–294. doi:10.1158/1055-9965.EPI-06-0756. PMID 17267388.
Singh GK, Miller BA, Hankey BF, Edwards BK (September 2004). "Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975–2000". Cancer. 101 (5): 1051–1057. doi:10.1002/cncr.20467. PMID 15329915. S2CID 26033629.
Peterson CE, Silva A, Goben AH, Ongtengco NP, Hu EZ, Khanna D, Nussbaum ER, Jasenof IG, Kim SJ, Dykens JA (December 2021). "Stigma and cervical cancer prevention: A scoping review of the U.S. literature". Prev Med. 153: 106849. doi:10.1016/j.ypmed.2021.106849. PMID 34662598. S2CID 239027566.
Peitzmeier SM, Bernstein IM, McDowell MJ, Pardee DJ, Agénor M, Alizaga NM, et al. (December 2020). "Enacting power and constructing gender in cervical cancer screening encounters between transmasculine patients and health care providers". Culture, Health & Sexuality. 22 (12): 1315–1332. doi:10.1080/13691058.2019.1677942. PMC 7188565. PMID 31661659.
Potter J, Peitzmeier SM, Bernstein I, Reisner SL, Alizaga NM, Agénor M, Pardee DJ (December 2015). "Cervical Cancer Screening for Patients on the Female-to-Male Spectrum: a Narrative Review and Guide for Clinicians". Journal of General Internal Medicine. 30 (12): 1857–1864. doi:10.1007/s11606-015-3462-8. PMC 4636588. PMID 26160483.
Agénor M, Peitzmeier SM, Bernstein IM, McDowell M, Alizaga NM, Reisner SL, et al. (October 2016). "Perceptions of cervical cancer risk and screening among transmasculine individuals: patient and provider perspectives". Culture, Health & Sexuality. 18 (10): 1192–1206. doi:10.1080/13691058.2016.1177203. PMID 27142466. S2CID 22036018.
Labanca T, Mañero I, Pannunzio M (December 2020). "Transgender patients: considerations for routine gynecologic care and cancer screening". International Journal of Gynecological Cancer. 30 (12): 1990–1996. doi:10.1136/ijgc-2020-001860. PMID 33109526. S2CID 225096075.

emedicine.com

Garcia A, Hamid O, El-Khoueiry A (6 July 2006). "Cervical Cancer". eMedicine. WebMD. Archived from the original on 9 December 2007. Retrieved 2 December 2007.

fda.gov

"FDA approves Gardasil 9 for prevention of certain cancers caused by five additional types of HPV". U.S. Food and Drug Administration. 10 December 2014. Archived from the original on 10 January 2015. Retrieved 8 March 2015.
"FDA Approves First Drug Treatment for Late-Stage Cervical Cancer". U.S. Food and Drug Administration. 15 June 2006. Archived from the original on 10 October 2007. Retrieved 2 December 2007.
"FDA Approves Pembrolizumab for Advanced Cervical Cancer". U.S. Food and Drug Administration. 12 June 2018. Archived from the original on 10 January 2022. Retrieved 12 January 2025.
"FDA Approves Pembrolizumab for Cervical Cancer with a New Dosing Regimen". U.S. Food and Drug Administration. 13 October 2021. Archived from the original on 10 January 2022. Retrieved 12 January 2025.
"FDA Approves Cemiplimab-rwlc for Recurrent or Metastatic Cervical Cancer with Disease Progression on or after Chemotherapy". U.S. Food and Drug Administration. 29 September 2022. Archived from the original on 1 January 2023. Retrieved 12 January 2025.

accessdata.fda.gov

"Enforcement Reports" (PDF). Archived from the original (PDF) on 21 September 2021. Retrieved 21 September 2021.

figshare.com

Peterson CE, Silva A, Goben AH, Ongtengco NP, Hu EZ, Khanna D, Nussbaum ER, Jasenof IG, Kim SJ, Dykens JA (December 2021). "Stigma and cervical cancer prevention: A scoping review of the U.S. literature". Prev Med. 153: 106849. doi:10.1016/j.ypmed.2021.106849. PMID 34662598. S2CID 239027566.

handle.net

hdl.handle.net

World Health Organization (December 2022). "Human papillomavirus vaccines: WHO position paper (2022 update)". Weekly Epidemiological Record. 97 (50): 645–672. hdl:10665/365351.
Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, et al. (February 2003). "Epidemiologic classification of human papillomavirus types associated with cervical cancer". The New England Journal of Medicine. 348 (6): 518–527. doi:10.1056/NEJMoa021641. hdl:2445/122831. PMID 12571259. S2CID 1451343.
Myung SK, Ju W, Kim SC, Kim H (October 2011). "Vitamin or antioxidant intake (or serum level) and risk of cervical neoplasm: a meta-analysis". BJOG. 118 (11): 1285–1291. doi:10.1111/j.1471-0528.2011.03032.x. hdl:2027.42/86903. PMID 21749626. S2CID 38761694.

harvard.edu

ui.adsabs.harvard.edu

Dürst M, Gissmann L, Ikenberg H, zur Hausen H (June 1983). "A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions". Proceedings of the National Academy of Sciences of the United States of America. 80 (12): 3812–3815. Bibcode:1983PNAS...80.3812D. doi:10.1073/pnas.80.12.3812. PMC 394142. PMID 6304740..

health.am

"Cervical Cancer". Cervical Cancer: Pathology, Symptoms and Signs, Diagnosis, Prognosis and Treatment. Armenian Health Network, Health.am. Archived from the original on 7 February 2007.

iarc.fr

screening.iarc.fr

Sellors JW (2003). "Chapter 4: An introduction to colposcopy: indications for colposcopy, instrumentation, principles and documentation of results". Colposcopy and treatment of cervical intraepithelial neoplasia: a beginners' manual. International Agency for Research on Cancer. ISBN 978-92-832-0412-1.

ima.org.il

Menczer J (February 2003). "The low incidence of cervical cancer in Jewish women: has the puzzle finally been solved?". The Israel Medical Association Journal. 5 (2): 120–123. PMID 12674663. Archived from the original on 8 December 2015. Retrieved 28 November 2015.

medicinenet.com

"Cervical Cancer Symptoms, Signs, Causes, Stages & Treatment". medicinenet.com.
"Cervical Cancer Symptoms, Signs, Causes, Stages & Treatment". medicinenet.com.

medlineplus.gov

"Cervical cancer". MedlinePlus Medical Encyclopedia. National Institutes of Health. 9 June 2006. Archived from the original on 11 October 2007. Retrieved 2 December 2007.

mydailynewsusa.com

"Eliminating Cervical Cancer in Nigeria: How Awareness, Infrastructure, and Government Support Can Make a Difference - My Daily News Usa". 4 April 2023. Archived from the original on 15 April 2023. Retrieved 15 April 2023.
Sahana DU (4 April 2023). "Eliminating Cervical Cancer in Nigeria: How Awareness, Infrastructure, and Government Support Can Make a Difference". My Daily News Usa. Archived from the original on 15 April 2023. Retrieved 15 April 2023.

nhs.uk

"Should trans men have cervical screening tests?". nhs.uk. 27 June 2018. Retrieved 21 January 2023.
"Causes of cervical cancer". nhs.uk. 20 October 2017. Retrieved 21 January 2023.

nih.gov

pubmed.ncbi.nlm.nih.gov

Bosch FX, de Sanjosé S (2007). "The epidemiology of human papillomavirus infection and cervical cancer". Disease Markers. 23 (4): 213–227. doi:10.1155/2007/914823. PMC 3850867. PMID 17627057.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (May 2021). "Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries". CA: A Cancer Journal for Clinicians. 71 (3): 209–249. doi:10.3322/caac.21660. PMID 33538338. S2CID 231804598.
Tarney CM, Han J (2014). "Postcoital bleeding: a review on etiology, diagnosis, and management". Obstetrics and Gynecology International. 2014: 192087. doi:10.1155/2014/192087. PMC 4086375. PMID 25045355.
Dunne EF, Park IU (December 2013). "HPV and HPV-associated diseases". Infectious Disease Clinics of North America. 27 (4): 765–778. doi:10.1016/j.idc.2013.09.001. PMID 24275269.
Ramachandran D, Dörk T (October 2021). "Genomic Risk Factors for Cervical Cancer". Cancers. 13 (20): 5137. doi:10.3390/cancers13205137. PMC 8533931. PMID 34680286.
Tran NP, Hung CF, Roden R, Wu TC (2014). "Control of HPV Infection and Related Cancer Through Vaccination". Viruses and Human Cancer. Recent Results in Cancer Research. Vol. 193. pp. 149–171. doi:10.1007/978-3-642-38965-8_9. ISBN 978-3-642-38964-1. PMID 24008298.
Donnez J (April 2020). "An update on uterine cervix pathologies related to infertility". Fertility and Sterility. 113 (4): 683–684. doi:10.1016/j.fertnstert.2020.02.107. PMID 32228872.
Canavan TP, Doshi NR (March 2000). "Cervical cancer". American Family Physician. 61 (5): 1369–1376. PMID 10735343. Archived from the original on 6 February 2005.
Canfell K, Kim JJ, Brisson M, Keane A, Simms KT, Caruana M, et al. (February 2020). "Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries". Lancet. 395 (10224): 591–603. doi:10.1016/S0140-6736(20)30157-4. PMC 7043006. PMID 32007142.
Li H, Wu X, Cheng X (July 2016). "Advances in diagnosis and treatment of metastatic cervical cancer". Journal of Gynecologic Oncology. 27 (4): e43. doi:10.3802/jgo.2016.27.e43. PMC 4864519. PMID 27171673.
Gadducci A, Barsotti C, Cosio S, Domenici L, Riccardo Genazzani A (August 2011). "Smoking habit, immune suppression, oral contraceptive use, and hormone replacement therapy use and cervical carcinogenesis: a review of the literature". Gynecological Endocrinology. 27 (8): 597–604. doi:10.3109/09513590.2011.558953. PMID 21438669. S2CID 25447563.
Snijders PJ, Steenbergen RD, Heideman DA, Meijer CJ (January 2006). "HPV-mediated cervical carcinogenesis: concepts and clinical implications". The Journal of Pathology. 208 (2): 152–164. doi:10.1002/path.1866. PMID 16362994. S2CID 25400770.
Marrazzo JM, Koutsky LA, Kiviat NB, Kuypers JM, Stine K (June 2001). "Papanicolaou test screening and prevalence of genital human papillomavirus among women who have sex with women". American Journal of Public Health. 91 (6): 947–952. doi:10.2105/AJPH.91.6.947. PMC 1446473. PMID 11392939.
Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, et al. (February 2003). "Epidemiologic classification of human papillomavirus types associated with cervical cancer". The New England Journal of Medicine. 348 (6): 518–527. doi:10.1056/NEJMoa021641. hdl:2445/122831. PMID 12571259. S2CID 1451343.
Luhn P, Walker J, Schiffman M, Zuna RE, Dunn ST, Gold MA, et al. (February 2013). "The role of co-factors in the progression from human papillomavirus infection to cervical cancer". Gynecologic Oncology. 128 (2): 265–270. doi:10.1016/j.ygyno.2012.11.003. PMC 4627848. PMID 23146688.
Remschmidt C, Kaufmann AM, Hagemann I, Vartazarova E, Wichmann O, Deleré Y (March 2013). "Risk factors for cervical human papillomavirus infection and high-grade intraepithelial lesion in women aged 20 to 31 years in Germany". International Journal of Gynecological Cancer. 23 (3): 519–526. doi:10.1097/IGC.0b013e318285a4b2. PMID 23360813. S2CID 205679729.
Agorastos T, Miliaras D, Lambropoulos AF, Chrisafi S, Kotsis A, Manthos A, Bontis J (July 2005). "Detection and typing of human papillomavirus DNA in uterine cervices with coexistent grade I and grade III intraepithelial neoplasia: biologic progression or independent lesions?". European Journal of Obstetrics, Gynecology, and Reproductive Biology. 121 (1): 99–103. doi:10.1016/j.ejogrb.2004.11.024. PMID 15949888.
Jensen KE, Schmiedel S, Frederiksen K, Norrild B, Iftner T, Kjær SK (November 2012). "Risk for cervical intraepithelial neoplasia grade 3 or worse in relation to smoking among women with persistent human papillomavirus infection". Cancer Epidemiology, Biomarkers & Prevention. 21 (11): 1949–1955. doi:10.1158/1055-9965.EPI-12-0663. PMC 3970163. PMID 23019238.
Asthana S, Busa V, Labani S (April 2020). "Oral contraceptives use and risk of cervical cancer-A systematic review & meta-analysis". European Journal of Obstetrics, Gynecology, and Reproductive Biology. 247: 163–175. doi:10.1016/j.ejogrb.2020.02.014. PMID 32114321. S2CID 211728228.
Cronjé HS (February 2004). "Screening for cervical cancer in developing countries". International Journal of Gynaecology and Obstetrics. 84 (2): 101–108. doi:10.1016/j.ijgo.2003.09.009. PMID 14871510. S2CID 21356776.
Athanasiou A, Veroniki AA, Efthimiou O, Kalliala I, Naci H, Bowden S, et al. (August 2022). "Comparative effectiveness and risk of preterm birth of local treatments for cervical intraepithelial neoplasia and stage IA1 cervical cancer: a systematic review and network meta-analysis". The Lancet. Oncology. 23 (8): 1097–1108. doi:10.1016/S1470-2045(22)00334-5. PMC 9630146. PMID 35835138.
Pannu HK, Corl FM, Fishman EK (September–October 2001). "CT evaluation of cervical cancer: spectrum of disease". Radiographics. 21 (5): 1155–1168. doi:10.1148/radiographics.21.5.g01se311155. PMID 11553823.
Galaal K, Bryant A, Deane KH, Al-Khaduri M, Lopes AD (December 2011). "Interventions for reducing anxiety in women undergoing colposcopy". The Cochrane Database of Systematic Reviews. 2022 (12): CD006013. doi:10.1002/14651858.cd006013.pub3. PMC 4161490. PMID 22161395.
Mello V, Sundstrom RK (2023). "Cervical Intraepithelial Neoplasia". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 31335091. Retrieved 16 November 2023.
Image by Mikael Häggström, MD. Source for caption: Ghosh A, Nirupama M, Padmanabha N, Kini H (2020). "Assessment of p16 and Ki67 Immunohistochemistry Expression in Squamous Intraepithelial Lesion with Cytohistomorphological Correlation". Iran J Pathol. 15 (4): 268–273. doi:10.30699/ijp.2020.112421.2208. PMC 7477676. PMID 32944038.
Mulita F, Iliopoulos F, Kehagias I (September 2020). "A rare case of gastric-type mucinous endocervical adenocarcinoma in a 59-year-old woman". Przeglad Menopauzalny = Menopause Review. 19 (3): 147–150. doi:10.5114/pm.2020.99563. PMC 7573334. PMID 33100952.
Bhatla N, Berek JS, Cuello Fredes M, Denny LA, Grenman S, Karunaratne K, et al. (April 2019). "Revised FIGO staging for carcinoma of the cervix uteri". International Journal of Gynaecology and Obstetrics. 145 (1): 129–135. doi:10.1002/ijgo.12749. PMID 30656645. S2CID 58656013.
Payne N, Chilcott J, McGoogan E (2000). "Liquid-based cytology in cervical screening: a rapid and systematic review". Health Technology Assessment. 4 (18): 1–73. doi:10.3310/hta4180. PMID 10932023.
Karnon J, Peters J, Platt J, Chilcott J, McGoogan E, Brewer N (May 2004). "Liquid-based cytology in cervical screening: an updated rapid and systematic review and economic analysis". Health Technology Assessment. 8 (20): iii, 1-iii, 78. doi:10.3310/hta8200. PMID 15147611.
Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U, Segnan N, et al. (March 2010). "European Guidelines for Quality Assurance in Cervical Cancer Screening. Second edition--summary document". Annals of Oncology. 21 (3): 448–458. doi:10.1093/annonc/mdp471. PMC 2826099. PMID 20176693.
Staley H, Shiraz A, Shreeve N, Bryant A, Martin-Hirsch PP, Gajjar K (September 2021). "Interventions targeted at women to encourage the uptake of cervical screening". The Cochrane Database of Systematic Reviews. 2021 (9): CD002834. doi:10.1002/14651858.CD002834.pub3. PMC 8543674. PMID 34694000.
Committee on Practice Bulletins—Gynecology (November 2012). "ACOG Practice Bulletin Number 131: Screening for cervical cancer". Obstetrics and Gynecology. 120 (5): 1222–1238. doi:10.1097/AOG.0b013e318277c92a. PMID 23090560.
Karjane N, Chelmow D (June 2013). "New cervical cancer screening guidelines, again". Obstetrics and Gynecology Clinics of North America. 40 (2): 211–223. doi:10.1016/j.ogc.2013.03.001. PMID 23732026.
Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, et al. (August 2018). "Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement". JAMA. 320 (7): 674–686. doi:10.1001/jama.2018.10897. PMID 30140884.
Arrossi S, Temin S, Garland S, Eckert LO, Bhatla N, Castellsagué X, et al. (October 2017). "Primary Prevention of Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Guideline". Journal of Global Oncology. 3 (5): 611–634. doi:10.1200/JGO.2016.008151. PMC 5646902. PMID 29094100.
Medeiros LR, Rosa DD, da Rosa MI, Bozzetti MC, Zanini RR (October 2009). "Efficacy of human papillomavirus vaccines: a systematic quantitative review". International Journal of Gynecological Cancer. 19 (7): 1166–1176. doi:10.1111/IGC.0b013e3181a3d100. PMID 19823051. S2CID 24695684.
Kitano, Taito (24 March 2022). "Risk-Benefit Analysis of the 9-Valent HPV Vaccination for Adolescent Boys from an Individual Perspective". Japanese Journal of Infectious Diseases. 75 (2): 114–120. doi:10.7883/yoken.JJID.2021.367. PMID 34334535.
Manhart LE, Koutsky LA (November 2002). "Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis". Sexually Transmitted Diseases. 29 (11): 725–735. doi:10.1097/00007435-200211000-00018. PMID 12438912. S2CID 9869956.
Zhang X, Dai B, Zhang B, Wang Z (February 2012). "Vitamin A and risk of cervical cancer: a meta-analysis". Gynecologic Oncology. 124 (2): 366–373. doi:10.1016/j.ygyno.2011.10.012. PMID 22005522.
Myung SK, Ju W, Kim SC, Kim H (October 2011). "Vitamin or antioxidant intake (or serum level) and risk of cervical neoplasm: a meta-analysis". BJOG. 118 (11): 1285–1291. doi:10.1111/j.1471-0528.2011.03032.x. hdl:2027.42/86903. PMID 21749626. S2CID 38761694.
Baalbergen A, Veenstra Y, Stalpers L (January 2013). "Primary surgery versus primary radiotherapy with or without chemotherapy for early adenocarcinoma of the uterine cervix". The Cochrane Database of Systematic Reviews. 2021 (1): CD006248. doi:10.1002/14651858.CD006248.pub3. PMC 7387233. PMID 23440805.
Einhorn N, Tropé C, Ridderheim M, Boman K, Sorbe B, Cavallin-Ståhl E (2003). "A systematic overview of radiation therapy effects in cervical cancer (cervix uteri)". Acta Oncologica. 42 (5–6): 546–556. doi:10.1080/02841860310014660. PMID 14596512.
Chemoradiotherapy for Cervical Cancer Meta-analysis Collaboration (CCCMAC) (January 2010). "Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis". The Cochrane Database of Systematic Reviews. 2010 (1): CD008285. doi:10.1002/14651858.cd008285. PMC 7105912. PMID 20091664.
Chau JP, Liu X, Lo SH, Chien WT, Hui SK, Choi KC, Zhao J (March 2022). "Perioperative enhanced recovery programmes for women with gynaecological cancers". The Cochrane Database of Systematic Reviews. 2022 (3): CD008239. doi:10.1002/14651858.CD008239.pub5. PMC 8922407. PMID 35289396.
van Nagell JR, Greenwell N, Powell DF, Donaldson ES, Hanson MB, Gay EC (April 1983). "Microinvasive carcinoma of the cervix". American Journal of Obstetrics and Gynecology. 145 (8): 981–991. doi:10.1016/0002-9378(83)90852-9. PMID 6837683.
Lin Y, Zhou J, Dai L, Cheng Y, Wang J (September 2017). "Vaginectomy and vaginoplasty for isolated vaginal recurrence 8 years after cervical cancer radical hysterectomy: A case report and literature review". The Journal of Obstetrics and Gynaecology Research. 43 (9): 1493–1497. doi:10.1111/jog.13375. PMID 28691384. S2CID 42161609.
Kokka F, Bryant A, Brockbank E, Jeyarajah A (May 2014). "Surgical treatment of stage IA2 cervical cancer". The Cochrane Database of Systematic Reviews. 2018 (5): CD010870. doi:10.1002/14651858.cd010870.pub2. PMC 6513277. PMID 24874726.
Jones WB, Mercer GO, Lewis JL, Rubin SC, Hoskins WJ (October 1993). "Early invasive carcinoma of the cervix". Gynecologic Oncology. 51 (1): 26–32. doi:10.1006/gyno.1993.1241. PMID 8244170.
Burnett AF (February 2006). "Radical trachelectomy with laparoscopic lymphadenectomy: review of oncologic and obstetrical outcomes". Current Opinion in Obstetrics & Gynecology. 18 (1): 8–13. doi:10.1097/01.gco.0000192968.75190.dc. PMID 16493253. S2CID 22958941.
Cibula D, Ungár L, Svárovský J, Zivný J, Freitag P (March 2005). "[Abdominal radical trachelectomy--technique and experience]". Ceska Gynekologie (in Czech). 70 (2): 117–122. PMID 15918265.
Plante M, Renaud MC, Hoskins IA, Roy M (July 2005). "Vaginal radical trachelectomy: a valuable fertility-preserving option in the management of early-stage cervical cancer. A series of 50 pregnancies and review of the literature". Gynecologic Oncology. 98 (1): 3–10. doi:10.1016/j.ygyno.2005.04.014. PMID 15936061.
Roy M, Plante M, Renaud MC, Têtu B (September 1996). "Vaginal radical hysterectomy versus abdominal radical hysterectomy in the treatment of early-stage cervical cancer". Gynecologic Oncology. 62 (3): 336–339. doi:10.1006/gyno.1996.0245. PMID 8812529.
Dargent D, Martin X, Sacchetoni A, Mathevet P (April 2000). "Laparoscopic vaginal radical trachelectomy: a treatment to preserve the fertility of cervical carcinoma patients". Cancer. 88 (8): 1877–1882. doi:10.1002/(SICI)1097-0142(20000415)88:8<1877::AID-CNCR17>3.0.CO;2-W. PMID 10760765.
Schlaerth JB, Spirtos NM, Schlaerth AC (January 2003). "Radical trachelectomy and pelvic lymphadenectomy with uterine preservation in the treatment of cervical cancer". American Journal of Obstetrics and Gynecology. 188 (1): 29–34. doi:10.1067/mob.2003.124. PMID 12548192.
Rogers L, Siu SS, Luesley D, Bryant A, Dickinson HO (May 2012). "Radiotherapy and chemoradiation after surgery for early cervical cancer". The Cochrane Database of Systematic Reviews. 5 (5): CD007583. doi:10.1002/14651858.cd007583.pub3. PMC 4171000. PMID 22592722.
Waggoner SE (June 2003). "Cervical cancer". Lancet. 361 (9376): 2217–2225. doi:10.1016/S0140-6736(03)13778-6. PMID 12842378. S2CID 24115541.
Falcetta FS, Medeiros LR, Edelweiss MI, Pohlmann PR, Stein AT, Rosa DD (November 2016). "Adjuvant platinum-based chemotherapy for early stage cervical cancer". The Cochrane Database of Systematic Reviews. 11 (11): CD005342. doi:10.1002/14651858.CD005342.pub4. PMC 4164460. PMID 27873308.
Nama V, Angelopoulos G, Twigg J, Murdoch JB, Bailey J, Lawrie TA (October 2018). "Type II or type III radical hysterectomy compared to chemoradiotherapy as a primary intervention for stage IB2 cervical cancer". The Cochrane Database of Systematic Reviews. 2018 (10): CD011478. doi:10.1002/14651858.cd011478.pub2. PMC 6516889. PMID 30311942.
Moon JY, Song IC, Ko YB, Lee HJ (April 2018). "The combination of cisplatin and topotecan as a second-line treatment for patients with advanced/recurrent uterine cervix cancer". Medicine. 97 (14): e0340. doi:10.1097/MD.0000000000010340. PMC 5902288. PMID 29620661.
Tangjitgamol S, Katanyoo K, Laopaiboon M, Lumbiganon P, Manusirivithaya S, Supawattanabodee B (December 2014). "Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer". The Cochrane Database of Systematic Reviews. 2019 (12): CD010401. doi:10.1002/14651858.cd010401.pub2. PMC 6402532. PMID 25470408.
Sardain H, Lavoue V, Redpath M, Bertheuil N, Foucher F, Levêque J (August 2015). "Curative pelvic exenteration for recurrent cervical carcinoma in the era of concurrent chemotherapy and radiation therapy. A systematic review" (PDF). European Journal of Surgical Oncology. 41 (8): 975–985. doi:10.1016/j.ejso.2015.03.235. PMID 25922209. S2CID 21911045.
Lanceley A, Fiander A, McCormack M, Bryant A, et al. (Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group) (November 2013). "Follow-up protocols for women with cervical cancer after primary treatment". The Cochrane Database of Systematic Reviews. 2014 (11): CD008767. doi:10.1002/14651858.CD008767.pub2. PMC 8969617. PMID 24277645.
Eleje GU, Eke AC, Igberase GO, Igwegbe AO, Eleje LI (March 2019). "Palliative interventions for controlling vaginal bleeding in advanced cervical cancer". The Cochrane Database of Systematic Reviews. 3 (3): CD011000. doi:10.1002/14651858.cd011000.pub3. PMC 6423555. PMID 30888060.
Colomban L, Le Tourneau C (July 2022). "Immunotherapy in Cervical Cancer: Advances and Perspectives". Cancers (Basel). 14 (15): 3803. doi:10.3390/cancers14153803. PMC 9330146. PMID 35955074.
Mello V, Sundstrom RK (January 2022). "Cervical Intraepithelial Neoplasia.". StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. PMID 31335091.
Cohen, Camryn M.; Wentzensen, Nicolas; Castle, Philip E.; Schiffman, Mark; Zuna, Rosemary; Arend, Rebecca C.; Clarke, Megan A. (1 December 2022). "Racial and Ethnic Disparities in Cervical Cancer Incidence, Survival, and Mortality by Histologic Subtype". Journal of Clinical Oncology. 41 (5). ASCO Publications: 1059–1068. doi:10.1200/JCO.22.01424. PMC 9928618. PMID 36455190.
Nygård M (June 2011). "Screening for cervical cancer: when theory meets reality". BMC Cancer. 11: 240. doi:10.1186/1471-2407-11-240. PMC 3146446. PMID 21668947.
Muliira RS, Salas AS, O'Brien B (2016). "Quality of Life among Female Cancer Survivors in Africa: An Integrative Literature Review". Asia-Pacific Journal of Oncology Nursing. 4 (1): 6–17. doi:10.4103/2347-5625.199078. PMC 5297234. PMID 28217724.
Majeed, Hafsa; Gupta, Vikas (14 August 2023). Adverse Effects of Radiation Therapy. StatPearls Publishing LLC. PMID 33085406. NBK563259. Retrieved 24 October 2024.
Huh, Jung Wook; Tanksley, Jarred; Chino, Junzo; Willett, Christopher G.; Dewhirst, Mark W. (1 July 2020). "Long-term Consequences of Pelvic Irradiation: Toxicities, Challenges, and Therapeutic Opportunities with Pharmacologic Mitigators". Clinical Cancer Research. 26 (13): 3079–3090. doi:10.1158/1078-0432.CCR-19-2744. ISSN 1078-0432. PMID 32098770. Retrieved 24 October 2024.
Kent A (Winter 2010). "HPV Vaccination and Testing". Reviews in Obstetrics & Gynecology. 3 (1): 33–34. PMC 2876324. PMID 20508781.
Cordeiro CN, Gemignani ML (March 2017). "Gynecologic Malignancies in Pregnancy: Balancing Fetal Risks With Oncologic Safety". Obstetrical & Gynecological Survey. 72 (3): 184–193. doi:10.1097/OGX.0000000000000407. PMC 5358514. PMID 28304416.
Hall MT, Simms KT, Lew JB, Smith MA, Brotherton JM, Saville M, Frazer IH, Canfell K (January 2019). "The projected timeframe until cervical cancer elimination in Australia: a modelling study". The Lancet. Public Health. 4 (1): e19 – e27. doi:10.1016/S2468-2667(18)30183-X. PMID 30291040. S2CID 52924713.
G C B, G C A. Other countries should copy Nepal's approach to tackling cervical cancer. Nature. 2025 Feb;638(8052):891. doi:doi:10.1038/d41586-025-00589-z | PMID: PMID 40000865.
Krishnatreya M, Kataki AC, Sharma JD, Nandy P, Gogoi G (2015). "Association of educational levels with survival in Indian patients with cancer of the uterine cervix". Asian Pacific Journal of Cancer Prevention. 16 (8): 3121–3123. doi:10.7314/apjcp.2015.16.8.3121. PMID 25921107.
Armstrong EP (April 2010). "Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types". Journal of Managed Care Pharmacy. 16 (3): 217–230. doi:10.18553/jmcp.2010.16.3.217. PMC 10437588. PMID 20331326. S2CID 14373353.
zur Hausen H (May 2002). "Papillomaviruses and cancer: from basic studies to clinical application". Nature Reviews. Cancer. 2 (5): 342–350. doi:10.1038/nrc798. PMID 12044010. S2CID 4991177.
Beachler DC, Kreimer AR, Schiffman M, Herrero R, Wacholder S, Rodriguez AC, et al. (January 2016). "Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection". Journal of the National Cancer Institute. 108 (1): djv302. doi:10.1093/jnci/djv302. PMC 4862406. PMID 26467666.
Kreimer AR, Herrero R, Sampson JN, Porras C, Lowy DR, Schiller JT, et al. (August 2018). "Evidence for single-dose protection by the bivalent HPV vaccine-Review of the Costa Rica HPV vaccine trial and future research studies". Vaccine. 36 (32 Pt A): 4774–4782. doi:10.1016/j.vaccine.2017.12.078. PMC 6054558. PMID 29366703.
Menczer J (February 2003). "The low incidence of cervical cancer in Jewish women: has the puzzle finally been solved?". The Israel Medical Association Journal. 5 (2): 120–123. PMID 12674663. Archived from the original on 8 December 2015. Retrieved 28 November 2015.
Heins HC, Dennis EJ, Pratthomas HR (October 1958). "The possible role of smegma in carcinoma of the cervix". American Journal of Obstetrics and Gynecology. 76 (4): 726–33, discussion 733–5. doi:10.1016/0002-9378(58)90004-8. PMID 13583012.
Alexander ER (June 1973). "Possible etiologies of cancer of the cervix other than herpesvirus". Cancer Research. 33 (6): 1485–1490. PMID 4352386.
Dürst M, Gissmann L, Ikenberg H, zur Hausen H (June 1983). "A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions". Proceedings of the National Academy of Sciences of the United States of America. 80 (12): 3812–3815. Bibcode:1983PNAS...80.3812D. doi:10.1073/pnas.80.12.3812. PMC 394142. PMID 6304740..
Lowy DR, Schiller JT (May 2006). "Prophylactic human papillomavirus vaccines". The Journal of Clinical Investigation. 116 (5): 1167–1173. doi:10.1172/JCI28607. PMC 1451224. PMID 16670757.
McNeil C (April 2006). "Who invented the VLP cervical cancer vaccines?". Journal of the National Cancer Institute. 98 (7): 433. doi:10.1093/jnci/djj144. PMID 16595773.
Tiro JA, Meissner HI, Kobrin S, Chollette V (February 2007). "What do women in the U.S. know about human papillomavirus and cervical cancer?". Cancer Epidemiology, Biomarkers & Prevention. 16 (2): 288–294. doi:10.1158/1055-9965.EPI-06-0756. PMID 17267388.
Singh GK, Miller BA, Hankey BF, Edwards BK (September 2004). "Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975–2000". Cancer. 101 (5): 1051–1057. doi:10.1002/cncr.20467. PMID 15329915. S2CID 26033629.
Peterson CE, Silva A, Goben AH, Ongtengco NP, Hu EZ, Khanna D, Nussbaum ER, Jasenof IG, Kim SJ, Dykens JA (December 2021). "Stigma and cervical cancer prevention: A scoping review of the U.S. literature". Prev Med. 153: 106849. doi:10.1016/j.ypmed.2021.106849. PMID 34662598. S2CID 239027566.
Peitzmeier SM, Bernstein IM, McDowell MJ, Pardee DJ, Agénor M, Alizaga NM, et al. (December 2020). "Enacting power and constructing gender in cervical cancer screening encounters between transmasculine patients and health care providers". Culture, Health & Sexuality. 22 (12): 1315–1332. doi:10.1080/13691058.2019.1677942. PMC 7188565. PMID 31661659.
Potter J, Peitzmeier SM, Bernstein I, Reisner SL, Alizaga NM, Agénor M, Pardee DJ (December 2015). "Cervical Cancer Screening for Patients on the Female-to-Male Spectrum: a Narrative Review and Guide for Clinicians". Journal of General Internal Medicine. 30 (12): 1857–1864. doi:10.1007/s11606-015-3462-8. PMC 4636588. PMID 26160483.
Agénor M, Peitzmeier SM, Bernstein IM, McDowell M, Alizaga NM, Reisner SL, et al. (October 2016). "Perceptions of cervical cancer risk and screening among transmasculine individuals: patient and provider perspectives". Culture, Health & Sexuality. 18 (10): 1192–1206. doi:10.1080/13691058.2016.1177203. PMID 27142466. S2CID 22036018.
Labanca T, Mañero I, Pannunzio M (December 2020). "Transgender patients: considerations for routine gynecologic care and cancer screening". International Journal of Gynecological Cancer. 30 (12): 1990–1996. doi:10.1136/ijgc-2020-001860. PMID 33109526. S2CID 225096075.

ncbi.nlm.nih.gov

Bosch FX, de Sanjosé S (2007). "The epidemiology of human papillomavirus infection and cervical cancer". Disease Markers. 23 (4): 213–227. doi:10.1155/2007/914823. PMC 3850867. PMID 17627057.
Tarney CM, Han J (2014). "Postcoital bleeding: a review on etiology, diagnosis, and management". Obstetrics and Gynecology International. 2014: 192087. doi:10.1155/2014/192087. PMC 4086375. PMID 25045355.
Ramachandran D, Dörk T (October 2021). "Genomic Risk Factors for Cervical Cancer". Cancers. 13 (20): 5137. doi:10.3390/cancers13205137. PMC 8533931. PMID 34680286.
Canfell K, Kim JJ, Brisson M, Keane A, Simms KT, Caruana M, et al. (February 2020). "Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries". Lancet. 395 (10224): 591–603. doi:10.1016/S0140-6736(20)30157-4. PMC 7043006. PMID 32007142.
Li H, Wu X, Cheng X (July 2016). "Advances in diagnosis and treatment of metastatic cervical cancer". Journal of Gynecologic Oncology. 27 (4): e43. doi:10.3802/jgo.2016.27.e43. PMC 4864519. PMID 27171673.
Marrazzo JM, Koutsky LA, Kiviat NB, Kuypers JM, Stine K (June 2001). "Papanicolaou test screening and prevalence of genital human papillomavirus among women who have sex with women". American Journal of Public Health. 91 (6): 947–952. doi:10.2105/AJPH.91.6.947. PMC 1446473. PMID 11392939.
Luhn P, Walker J, Schiffman M, Zuna RE, Dunn ST, Gold MA, et al. (February 2013). "The role of co-factors in the progression from human papillomavirus infection to cervical cancer". Gynecologic Oncology. 128 (2): 265–270. doi:10.1016/j.ygyno.2012.11.003. PMC 4627848. PMID 23146688.
Jensen KE, Schmiedel S, Frederiksen K, Norrild B, Iftner T, Kjær SK (November 2012). "Risk for cervical intraepithelial neoplasia grade 3 or worse in relation to smoking among women with persistent human papillomavirus infection". Cancer Epidemiology, Biomarkers & Prevention. 21 (11): 1949–1955. doi:10.1158/1055-9965.EPI-12-0663. PMC 3970163. PMID 23019238.
Athanasiou A, Veroniki AA, Efthimiou O, Kalliala I, Naci H, Bowden S, et al. (August 2022). "Comparative effectiveness and risk of preterm birth of local treatments for cervical intraepithelial neoplasia and stage IA1 cervical cancer: a systematic review and network meta-analysis". The Lancet. Oncology. 23 (8): 1097–1108. doi:10.1016/S1470-2045(22)00334-5. PMC 9630146. PMID 35835138.
Galaal K, Bryant A, Deane KH, Al-Khaduri M, Lopes AD (December 2011). "Interventions for reducing anxiety in women undergoing colposcopy". The Cochrane Database of Systematic Reviews. 2022 (12): CD006013. doi:10.1002/14651858.cd006013.pub3. PMC 4161490. PMID 22161395.
Mello V, Sundstrom RK (2023). "Cervical Intraepithelial Neoplasia". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 31335091. Retrieved 16 November 2023.
Image by Mikael Häggström, MD. Source for caption: Ghosh A, Nirupama M, Padmanabha N, Kini H (2020). "Assessment of p16 and Ki67 Immunohistochemistry Expression in Squamous Intraepithelial Lesion with Cytohistomorphological Correlation". Iran J Pathol. 15 (4): 268–273. doi:10.30699/ijp.2020.112421.2208. PMC 7477676. PMID 32944038.
Mulita F, Iliopoulos F, Kehagias I (September 2020). "A rare case of gastric-type mucinous endocervical adenocarcinoma in a 59-year-old woman". Przeglad Menopauzalny = Menopause Review. 19 (3): 147–150. doi:10.5114/pm.2020.99563. PMC 7573334. PMID 33100952.
Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U, Segnan N, et al. (March 2010). "European Guidelines for Quality Assurance in Cervical Cancer Screening. Second edition--summary document". Annals of Oncology. 21 (3): 448–458. doi:10.1093/annonc/mdp471. PMC 2826099. PMID 20176693.
Staley H, Shiraz A, Shreeve N, Bryant A, Martin-Hirsch PP, Gajjar K (September 2021). "Interventions targeted at women to encourage the uptake of cervical screening". The Cochrane Database of Systematic Reviews. 2021 (9): CD002834. doi:10.1002/14651858.CD002834.pub3. PMC 8543674. PMID 34694000.
Arrossi S, Temin S, Garland S, Eckert LO, Bhatla N, Castellsagué X, et al. (October 2017). "Primary Prevention of Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Guideline". Journal of Global Oncology. 3 (5): 611–634. doi:10.1200/JGO.2016.008151. PMC 5646902. PMID 29094100.
Baalbergen A, Veenstra Y, Stalpers L (January 2013). "Primary surgery versus primary radiotherapy with or without chemotherapy for early adenocarcinoma of the uterine cervix". The Cochrane Database of Systematic Reviews. 2021 (1): CD006248. doi:10.1002/14651858.CD006248.pub3. PMC 7387233. PMID 23440805.
Chemoradiotherapy for Cervical Cancer Meta-analysis Collaboration (CCCMAC) (January 2010). "Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis". The Cochrane Database of Systematic Reviews. 2010 (1): CD008285. doi:10.1002/14651858.cd008285. PMC 7105912. PMID 20091664.
Chau JP, Liu X, Lo SH, Chien WT, Hui SK, Choi KC, Zhao J (March 2022). "Perioperative enhanced recovery programmes for women with gynaecological cancers". The Cochrane Database of Systematic Reviews. 2022 (3): CD008239. doi:10.1002/14651858.CD008239.pub5. PMC 8922407. PMID 35289396.
Kokka F, Bryant A, Brockbank E, Jeyarajah A (May 2014). "Surgical treatment of stage IA2 cervical cancer". The Cochrane Database of Systematic Reviews. 2018 (5): CD010870. doi:10.1002/14651858.cd010870.pub2. PMC 6513277. PMID 24874726.
Rogers L, Siu SS, Luesley D, Bryant A, Dickinson HO (May 2012). "Radiotherapy and chemoradiation after surgery for early cervical cancer". The Cochrane Database of Systematic Reviews. 5 (5): CD007583. doi:10.1002/14651858.cd007583.pub3. PMC 4171000. PMID 22592722.
Falcetta FS, Medeiros LR, Edelweiss MI, Pohlmann PR, Stein AT, Rosa DD (November 2016). "Adjuvant platinum-based chemotherapy for early stage cervical cancer". The Cochrane Database of Systematic Reviews. 11 (11): CD005342. doi:10.1002/14651858.CD005342.pub4. PMC 4164460. PMID 27873308.
Nama V, Angelopoulos G, Twigg J, Murdoch JB, Bailey J, Lawrie TA (October 2018). "Type II or type III radical hysterectomy compared to chemoradiotherapy as a primary intervention for stage IB2 cervical cancer". The Cochrane Database of Systematic Reviews. 2018 (10): CD011478. doi:10.1002/14651858.cd011478.pub2. PMC 6516889. PMID 30311942.
Moon JY, Song IC, Ko YB, Lee HJ (April 2018). "The combination of cisplatin and topotecan as a second-line treatment for patients with advanced/recurrent uterine cervix cancer". Medicine. 97 (14): e0340. doi:10.1097/MD.0000000000010340. PMC 5902288. PMID 29620661.
Tangjitgamol S, Katanyoo K, Laopaiboon M, Lumbiganon P, Manusirivithaya S, Supawattanabodee B (December 2014). "Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer". The Cochrane Database of Systematic Reviews. 2019 (12): CD010401. doi:10.1002/14651858.cd010401.pub2. PMC 6402532. PMID 25470408.
Lanceley A, Fiander A, McCormack M, Bryant A, et al. (Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group) (November 2013). "Follow-up protocols for women with cervical cancer after primary treatment". The Cochrane Database of Systematic Reviews. 2014 (11): CD008767. doi:10.1002/14651858.CD008767.pub2. PMC 8969617. PMID 24277645.
Eleje GU, Eke AC, Igberase GO, Igwegbe AO, Eleje LI (March 2019). "Palliative interventions for controlling vaginal bleeding in advanced cervical cancer". The Cochrane Database of Systematic Reviews. 3 (3): CD011000. doi:10.1002/14651858.cd011000.pub3. PMC 6423555. PMID 30888060.
Colomban L, Le Tourneau C (July 2022). "Immunotherapy in Cervical Cancer: Advances and Perspectives". Cancers (Basel). 14 (15): 3803. doi:10.3390/cancers14153803. PMC 9330146. PMID 35955074.
Mello V, Sundstrom RK (January 2022). "Cervical Intraepithelial Neoplasia.". StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. PMID 31335091.
Cohen, Camryn M.; Wentzensen, Nicolas; Castle, Philip E.; Schiffman, Mark; Zuna, Rosemary; Arend, Rebecca C.; Clarke, Megan A. (1 December 2022). "Racial and Ethnic Disparities in Cervical Cancer Incidence, Survival, and Mortality by Histologic Subtype". Journal of Clinical Oncology. 41 (5). ASCO Publications: 1059–1068. doi:10.1200/JCO.22.01424. PMC 9928618. PMID 36455190.
Nygård M (June 2011). "Screening for cervical cancer: when theory meets reality". BMC Cancer. 11: 240. doi:10.1186/1471-2407-11-240. PMC 3146446. PMID 21668947.
Muliira RS, Salas AS, O'Brien B (2016). "Quality of Life among Female Cancer Survivors in Africa: An Integrative Literature Review". Asia-Pacific Journal of Oncology Nursing. 4 (1): 6–17. doi:10.4103/2347-5625.199078. PMC 5297234. PMID 28217724.
Majeed, Hafsa; Gupta, Vikas (14 August 2023). Adverse Effects of Radiation Therapy. StatPearls Publishing LLC. PMID 33085406. NBK563259. Retrieved 24 October 2024.
Kent A (Winter 2010). "HPV Vaccination and Testing". Reviews in Obstetrics & Gynecology. 3 (1): 33–34. PMC 2876324. PMID 20508781.
Cordeiro CN, Gemignani ML (March 2017). "Gynecologic Malignancies in Pregnancy: Balancing Fetal Risks With Oncologic Safety". Obstetrical & Gynecological Survey. 72 (3): 184–193. doi:10.1097/OGX.0000000000000407. PMC 5358514. PMID 28304416.
Armstrong EP (April 2010). "Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types". Journal of Managed Care Pharmacy. 16 (3): 217–230. doi:10.18553/jmcp.2010.16.3.217. PMC 10437588. PMID 20331326. S2CID 14373353.
Beachler DC, Kreimer AR, Schiffman M, Herrero R, Wacholder S, Rodriguez AC, et al. (January 2016). "Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection". Journal of the National Cancer Institute. 108 (1): djv302. doi:10.1093/jnci/djv302. PMC 4862406. PMID 26467666.
Kreimer AR, Herrero R, Sampson JN, Porras C, Lowy DR, Schiller JT, et al. (August 2018). "Evidence for single-dose protection by the bivalent HPV vaccine-Review of the Costa Rica HPV vaccine trial and future research studies". Vaccine. 36 (32 Pt A): 4774–4782. doi:10.1016/j.vaccine.2017.12.078. PMC 6054558. PMID 29366703.
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2007). "Studies of Animal Papillomaviruses". Human Papillomaviruses. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 90. Lyon, France: International Agency for Research on Cancer.
Dürst M, Gissmann L, Ikenberg H, zur Hausen H (June 1983). "A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions". Proceedings of the National Academy of Sciences of the United States of America. 80 (12): 3812–3815. Bibcode:1983PNAS...80.3812D. doi:10.1073/pnas.80.12.3812. PMC 394142. PMID 6304740..
Lowy DR, Schiller JT (May 2006). "Prophylactic human papillomavirus vaccines". The Journal of Clinical Investigation. 116 (5): 1167–1173. doi:10.1172/JCI28607. PMC 1451224. PMID 16670757.
Peitzmeier SM, Bernstein IM, McDowell MJ, Pardee DJ, Agénor M, Alizaga NM, et al. (December 2020). "Enacting power and constructing gender in cervical cancer screening encounters between transmasculine patients and health care providers". Culture, Health & Sexuality. 22 (12): 1315–1332. doi:10.1080/13691058.2019.1677942. PMC 7188565. PMID 31661659.
Potter J, Peitzmeier SM, Bernstein I, Reisner SL, Alizaga NM, Agénor M, Pardee DJ (December 2015). "Cervical Cancer Screening for Patients on the Female-to-Male Spectrum: a Narrative Review and Guide for Clinicians". Journal of General Internal Medicine. 30 (12): 1857–1864. doi:10.1007/s11606-015-3462-8. PMC 4636588. PMID 26160483.

nihr.ac.uk

evidence.nihr.ac.uk

"Prevention of cervical cancer: what are the risks and benefits of different treatments?". NIHR Evidence (Plain English summary). National Institute for Health and Care Research. 10 November 2023. doi:10.3310/nihrevidence_60599. S2CID 265201829.

nsw.gov.au

csp.nsw.gov.au

Cancer Institute NSW (2013). "Information about cervical screening for Aboriginal women". NSW Government. Archived from the original on 11 April 2013.

papscreen.org.au

"Incidence and mortality rates". January 1900. Archived from the original on 12 September 2009.
"Papscreen Victoria". Archived from the original on 14 March 2011. Retrieved 7 March 2011.

pathologyoutlines.com

Turashvili G. "Squamous cell carcinoma and variants". Pathology Outlines.
Image by Mikael Häggström, MD. Source for caption: Turashvili G. "Cervix - Squamous cell carcinoma and variants". Pathology Outlines. Last author update: 24 September 2020

plunes.com

"Plunes HealthCare - Surgery Experience Made Easy | Upto 50% Off". www.plunes.com.

sciencewa.net.au

Romano MA (17 October 2011). "Aboriginal cervical cancer rates parallel health inequity". Science Network Western Australia. Archived from the original on 14 May 2013.

semanticscholar.org

api.semanticscholar.org

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (May 2021). "Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries". CA: A Cancer Journal for Clinicians. 71 (3): 209–249. doi:10.3322/caac.21660. PMID 33538338. S2CID 231804598.
Gadducci A, Barsotti C, Cosio S, Domenici L, Riccardo Genazzani A (August 2011). "Smoking habit, immune suppression, oral contraceptive use, and hormone replacement therapy use and cervical carcinogenesis: a review of the literature". Gynecological Endocrinology. 27 (8): 597–604. doi:10.3109/09513590.2011.558953. PMID 21438669. S2CID 25447563.
Snijders PJ, Steenbergen RD, Heideman DA, Meijer CJ (January 2006). "HPV-mediated cervical carcinogenesis: concepts and clinical implications". The Journal of Pathology. 208 (2): 152–164. doi:10.1002/path.1866. PMID 16362994. S2CID 25400770.
Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, et al. (February 2003). "Epidemiologic classification of human papillomavirus types associated with cervical cancer". The New England Journal of Medicine. 348 (6): 518–527. doi:10.1056/NEJMoa021641. hdl:2445/122831. PMID 12571259. S2CID 1451343.
Remschmidt C, Kaufmann AM, Hagemann I, Vartazarova E, Wichmann O, Deleré Y (March 2013). "Risk factors for cervical human papillomavirus infection and high-grade intraepithelial lesion in women aged 20 to 31 years in Germany". International Journal of Gynecological Cancer. 23 (3): 519–526. doi:10.1097/IGC.0b013e318285a4b2. PMID 23360813. S2CID 205679729.
Asthana S, Busa V, Labani S (April 2020). "Oral contraceptives use and risk of cervical cancer-A systematic review & meta-analysis". European Journal of Obstetrics, Gynecology, and Reproductive Biology. 247: 163–175. doi:10.1016/j.ejogrb.2020.02.014. PMID 32114321. S2CID 211728228.
Cronjé HS (February 2004). "Screening for cervical cancer in developing countries". International Journal of Gynaecology and Obstetrics. 84 (2): 101–108. doi:10.1016/j.ijgo.2003.09.009. PMID 14871510. S2CID 21356776.
"Prevention of cervical cancer: what are the risks and benefits of different treatments?". NIHR Evidence (Plain English summary). National Institute for Health and Care Research. 10 November 2023. doi:10.3310/nihrevidence_60599. S2CID 265201829.
Bhatla N, Berek JS, Cuello Fredes M, Denny LA, Grenman S, Karunaratne K, et al. (April 2019). "Revised FIGO staging for carcinoma of the cervix uteri". International Journal of Gynaecology and Obstetrics. 145 (1): 129–135. doi:10.1002/ijgo.12749. PMID 30656645. S2CID 58656013.
Medeiros LR, Rosa DD, da Rosa MI, Bozzetti MC, Zanini RR (October 2009). "Efficacy of human papillomavirus vaccines: a systematic quantitative review". International Journal of Gynecological Cancer. 19 (7): 1166–1176. doi:10.1111/IGC.0b013e3181a3d100. PMID 19823051. S2CID 24695684.
Manhart LE, Koutsky LA (November 2002). "Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis". Sexually Transmitted Diseases. 29 (11): 725–735. doi:10.1097/00007435-200211000-00018. PMID 12438912. S2CID 9869956.
Myung SK, Ju W, Kim SC, Kim H (October 2011). "Vitamin or antioxidant intake (or serum level) and risk of cervical neoplasm: a meta-analysis". BJOG. 118 (11): 1285–1291. doi:10.1111/j.1471-0528.2011.03032.x. hdl:2027.42/86903. PMID 21749626. S2CID 38761694.
Lin Y, Zhou J, Dai L, Cheng Y, Wang J (September 2017). "Vaginectomy and vaginoplasty for isolated vaginal recurrence 8 years after cervical cancer radical hysterectomy: A case report and literature review". The Journal of Obstetrics and Gynaecology Research. 43 (9): 1493–1497. doi:10.1111/jog.13375. PMID 28691384. S2CID 42161609.
Burnett AF (February 2006). "Radical trachelectomy with laparoscopic lymphadenectomy: review of oncologic and obstetrical outcomes". Current Opinion in Obstetrics & Gynecology. 18 (1): 8–13. doi:10.1097/01.gco.0000192968.75190.dc. PMID 16493253. S2CID 22958941.
Waggoner SE (June 2003). "Cervical cancer". Lancet. 361 (9376): 2217–2225. doi:10.1016/S0140-6736(03)13778-6. PMID 12842378. S2CID 24115541.
Sardain H, Lavoue V, Redpath M, Bertheuil N, Foucher F, Levêque J (August 2015). "Curative pelvic exenteration for recurrent cervical carcinoma in the era of concurrent chemotherapy and radiation therapy. A systematic review" (PDF). European Journal of Surgical Oncology. 41 (8): 975–985. doi:10.1016/j.ejso.2015.03.235. PMID 25922209. S2CID 21911045.
Dutta T, Meyerson B, Agley J (2018). "African cervical cancer prevention and control plans: A scoping review". Journal of Cancer Policy. 16: 73–81. doi:10.1016/j.jcpo.2018.05.002. S2CID 81552501.
Hall MT, Simms KT, Lew JB, Smith MA, Brotherton JM, Saville M, Frazer IH, Canfell K (January 2019). "The projected timeframe until cervical cancer elimination in Australia: a modelling study". The Lancet. Public Health. 4 (1): e19 – e27. doi:10.1016/S2468-2667(18)30183-X. PMID 30291040. S2CID 52924713.
Armstrong EP (April 2010). "Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types". Journal of Managed Care Pharmacy. 16 (3): 217–230. doi:10.18553/jmcp.2010.16.3.217. PMC 10437588. PMID 20331326. S2CID 14373353.
zur Hausen H (May 2002). "Papillomaviruses and cancer: from basic studies to clinical application". Nature Reviews. Cancer. 2 (5): 342–350. doi:10.1038/nrc798. PMID 12044010. S2CID 4991177.
Syverton, J. T.; Berry, G. P. (1935). "Carcinoma in the Cottontail Rabbit Following Spontaneous Virus Papilloma (Shope)". Experimental Biology and Medicine. 33 (3): 399–400. doi:10.3181/00379727-33-8386P. S2CID 88311393.
Singh GK, Miller BA, Hankey BF, Edwards BK (September 2004). "Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975–2000". Cancer. 101 (5): 1051–1057. doi:10.1002/cncr.20467. PMID 15329915. S2CID 26033629.
Peterson CE, Silva A, Goben AH, Ongtengco NP, Hu EZ, Khanna D, Nussbaum ER, Jasenof IG, Kim SJ, Dykens JA (December 2021). "Stigma and cervical cancer prevention: A scoping review of the U.S. literature". Prev Med. 153: 106849. doi:10.1016/j.ypmed.2021.106849. PMID 34662598. S2CID 239027566.
Agénor M, Peitzmeier SM, Bernstein IM, McDowell M, Alizaga NM, Reisner SL, et al. (October 2016). "Perceptions of cervical cancer risk and screening among transmasculine individuals: patient and provider perspectives". Culture, Health & Sexuality. 18 (10): 1192–1206. doi:10.1080/13691058.2016.1177203. PMID 27142466. S2CID 22036018.
Labanca T, Mañero I, Pannunzio M (December 2020). "Transgender patients: considerations for routine gynecologic care and cancer screening". International Journal of Gynecological Cancer. 30 (12): 1990–1996. doi:10.1136/ijgc-2020-001860. PMID 33109526. S2CID 225096075.

ucaldas.edu.co

revistasojs.ucaldas.edu.co

Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, et al. (February 2003). "Epidemiologic classification of human papillomavirus types associated with cervical cancer". The New England Journal of Medicine. 348 (6): 518–527. doi:10.1056/NEJMoa021641. hdl:2445/122831. PMID 12571259. S2CID 1451343.

un.org

news.un.org

"WHO rolls out plan to rid world of cervical cancer, saving millions of lives". UN News. 16 November 2020. Retrieved 27 November 2020.

upenn.edu

oncolink.upenn.edu

Dolinsky C (17 July 2006). "Cervical Cancer: The Basics". OncoLink. Abramson Cancer Center of the University of Pennsylvania. Archived from the original on 18 January 2008. Retrieved 2 December 2007.

web.archive.org

"Cervical Cancer Treatment (PDQ®)". NCI. 14 March 2014. Archived from the original on 5 July 2014. Retrieved 24 June 2014.
"Cervical Cancer Treatment (PDQ®)". National Cancer Institute. 14 March 2014. Archived from the original on 5 July 2014. Retrieved 25 June 2014.
Kufe D (2009). Holland-Frei cancer medicine (8th ed.). New York: McGraw-Hill Medical. p. 1299. ISBN 978-1-60795-014-1. Archived from the original on 1 December 2015.
"Cervical Cancer Prevention (PDQ®)". National Cancer Institute. 27 February 2014. Archived from the original on 6 July 2014. Retrieved 25 June 2014.
"Human Papillomavirus (HPV) Vaccines". National Cancer Institute. 29 December 2011. Archived from the original on 4 July 2014. Retrieved 25 June 2014.
"Global Cancer Facts & Figures 3rd Edition" (PDF). 2015. p. 9. Archived (PDF) from the original on 22 August 2017. Retrieved 29 August 2017.
"Defining Cancer". National Cancer Institute. 17 September 2007. Archived from the original on 25 June 2014. Retrieved 10 June 2014.
"Human papillomavirus vaccines (HPV)". World Health Organization. Archived from the original on 7 August 2024. Retrieved 29 September 2024.
"FDA approves Gardasil 9 for prevention of certain cancers caused by five additional types of HPV". U.S. Food and Drug Administration. 10 December 2014. Archived from the original on 10 January 2015. Retrieved 8 March 2015.
World Health Organization (February 2014). "Fact sheet No. 297: Cancer". Archived from the original on 13 February 2014. Retrieved 24 June 2014.
"SEER Stat Fact Sheets: Cervix Uteri Cancer". NCI. National Cancer Institute. 10 November 2014. Archived from the original on 6 July 2014. Retrieved 18 June 2014.
Canavan TP, Doshi NR (March 2000). "Cervical cancer". American Family Physician. 61 (5): 1369–1376. PMID 10735343. Archived from the original on 6 February 2005.
Carraher Jr CE (2014). Carraher's polymer chemistry (9th ed.). Boca Raton: Taylor & Francis. p. 385. ISBN 978-1-4665-5203-6. Archived from the original on 22 October 2015.
"Cervical Cancer Prevention and Early Detection". Cancer. Archived from the original on 10 July 2015.
"Cervical cancer". MedlinePlus Medical Encyclopedia. National Institutes of Health. 9 June 2006. Archived from the original on 11 October 2007. Retrieved 2 December 2007.
Dillman RK, Oldham RO, eds. (2009). Principles of cancer biotherapy (5th ed.). Dordrecht: Springer. p. 149. ISBN 978-90-481-2289-9. Archived from the original on 29 October 2015.
"What Causes Cancer of the Cervix?". American Cancer Society. 30 November 2006. Archived from the original on 13 October 2007. Retrieved 2 December 2007.
"Cancer Research UK website". Archived from the original on 16 January 2009. Retrieved 3 January 2009.
Garcia A, Hamid O, El-Khoueiry A (6 July 2006). "Cervical Cancer". eMedicine. WebMD. Archived from the original on 9 December 2007. Retrieved 2 December 2007.
Dolinsky C (17 July 2006). "Cervical Cancer: The Basics". OncoLink. Abramson Cancer Center of the University of Pennsylvania. Archived from the original on 18 January 2008. Retrieved 2 December 2007.
"Liquid Based Cytology (LBC): NHS Cervical Screening Programme". Archived from the original on 8 January 2011. Retrieved 1 October 2010.
"Cervical Cancer Screening Guidelines for Average-Risk Women" (PDF). cdc.gov. Archived (PDF) from the original on 1 February 2015. Retrieved 8 November 2014.
Comprehensive cervical cancer control. A guide to essential practice (Second ed.). World Health Organization. 2014. ISBN 978-92-4-154895-3. Archived from the original on 4 May 2015.
Erstad S (12 January 2007). "Cone biopsy (conization) for abnormal cervical cell changes". WebMD. Archived from the original on 19 November 2007. Retrieved 2 December 2007.
Dolson L (2001). "Trachelectomy". Archived from the original on 27 September 2007. Retrieved 2 December 2007.
"FDA Approves First Drug Treatment for Late-Stage Cervical Cancer". U.S. Food and Drug Administration. 15 June 2006. Archived from the original on 10 October 2007. Retrieved 2 December 2007.
"FDA Approves Pembrolizumab for Advanced Cervical Cancer". U.S. Food and Drug Administration. 12 June 2018. Archived from the original on 10 January 2022. Retrieved 12 January 2025.
"FDA Approves Pembrolizumab for Cervical Cancer with a New Dosing Regimen". U.S. Food and Drug Administration. 13 October 2021. Archived from the original on 10 January 2022. Retrieved 12 January 2025.
"FDA Approves Cemiplimab-rwlc for Recurrent or Metastatic Cervical Cancer with Disease Progression on or after Chemotherapy". U.S. Food and Drug Administration. 29 September 2022. Archived from the original on 1 January 2023. Retrieved 12 January 2025.
"Enforcement Reports" (PDF). Archived from the original (PDF) on 21 September 2021. Retrieved 21 September 2021.
"Survival Rates for Cervical Cancer". American Cancer Society. 3 January 2020. Archived from the original on 27 February 2022. Retrieved 27 February 2022.
"Cervical Cancer". Cervical Cancer: Pathology, Symptoms and Signs, Diagnosis, Prognosis and Treatment. Armenian Health Network, Health.am. Archived from the original on 7 February 2007.
"Cervical cancer statistics and prognosis". Cancer Research UK. Archived from the original on 20 May 2007. Retrieved 24 March 2007.
"WHO Disease and injury country estimates". World Health Organization. 2009. Archived from the original on 11 November 2009. Retrieved 11 November 2009.
"Incidence and mortality rates". January 1900. Archived from the original on 12 September 2009.
"Papscreen Victoria". Archived from the original on 14 March 2011. Retrieved 7 March 2011.
"Cervical cancer statistics". Cancer Research UK. Archived from the original on 7 October 2014. Retrieved 27 October 2014.
"Eliminating Cervical Cancer in Nigeria: How Awareness, Infrastructure, and Government Support Can Make a Difference - My Daily News Usa". 4 April 2023. Archived from the original on 15 April 2023. Retrieved 15 April 2023.
Sahana DU (4 April 2023). "Eliminating Cervical Cancer in Nigeria: How Awareness, Infrastructure, and Government Support Can Make a Difference". My Daily News Usa. Archived from the original on 15 April 2023. Retrieved 15 April 2023.
Menczer J (February 2003). "The low incidence of cervical cancer in Jewish women: has the puzzle finally been solved?". The Israel Medical Association Journal. 5 (2): 120–123. PMID 12674663. Archived from the original on 8 December 2015. Retrieved 28 November 2015.
Cancer Institute NSW (2013). "Information about cervical screening for Aboriginal women". NSW Government. Archived from the original on 11 April 2013.
Romano MA (17 October 2011). "Aboriginal cervical cancer rates parallel health inequity". Science Network Western Australia. Archived from the original on 14 May 2013.
Australian Cervical Cancer Foundation. "Vision and Mission". Australian Cervical Cancer Foundation. Archived from the original on 12 May 2013.
Australian Cervical Cancer Foundation. "Our People". Australian Cervical Cancer Foundation. Archived from the original on 12 May 2013.
Bradford G (16 October 2006). "Janette Howard speaks on her battle with cervical cancer". Australian Broadcasting Corporation. Archived from the original on 3 November 2012.

webmd.com

Erstad S (12 January 2007). "Cone biopsy (conization) for abnormal cervical cell changes". WebMD. Archived from the original on 19 November 2007. Retrieved 2 December 2007.

who.int

"Immunizing against HPV". World Health Organization. Retrieved 6 October 2024.
"Human papillomavirus vaccines (HPV)". World Health Organization. Archived from the original on 7 August 2024. Retrieved 29 September 2024.
"Cervical cancer". www.who.int. Retrieved 13 May 2022.
"Immunization coverage". World Health Organization. 15 July 2024. Retrieved 6 October 2024.
World Health Organization (February 2014). "Fact sheet No. 297: Cancer". Archived from the original on 13 February 2014. Retrieved 24 June 2014.
WHO (5 March 2024). "Cervical cancer". WHIO. Retrieved 23 September 2024.
"WHO adds an HPV vaccine for single-dose use". World Health Organization. 4 October 2024. Retrieved 6 October 2024.
"Cervical cancer prevention and control saves lives in the Republic of Korea". World Health Organization. Retrieved 1 November 2018.
"WHO adds an HPV vaccine for single-dose use". World Health Organization. 4 October 2024. Retrieved 5 October 2024.
"Cervical Cancer Elimination Day of Action". World Health Organization. Retrieved 6 October 2024.
"Global partners cheer progress towards eliminating cervical cancer and underline challenges". World Health Organization. 17 November 2023. Retrieved 6 October 2024.
"Global strategy to accelerate the elimination of cervical cancer as a public health problem". World Health Organization. 17 November 2020. Retrieved 6 October 2024.
Comprehensive cervical cancer control. A guide to essential practice (Second ed.). World Health Organization. 2014. ISBN 978-92-4-154895-3. Archived from the original on 4 May 2015.
"WHO Disease and injury country estimates". World Health Organization. 2009. Archived from the original on 11 November 2009. Retrieved 11 November 2009.
"The cancer we can eliminate – WHO/Europe urges Member States to consign cervical cancer to history". www.who.int. Retrieved 21 January 2023.

worldcat.org

search.worldcat.org

Huh, Jung Wook; Tanksley, Jarred; Chino, Junzo; Willett, Christopher G.; Dewhirst, Mark W. (1 July 2020). "Long-term Consequences of Pelvic Irradiation: Toxicities, Challenges, and Therapeutic Opportunities with Pharmacologic Mitigators". Clinical Cancer Research. 26 (13): 3079–3090. doi:10.1158/1078-0432.CCR-19-2744. ISSN 1078-0432. PMID 32098770. Retrieved 24 October 2024.